Medicinal properties of Echinacea: A critical review

Phytomedicine

Volumn 10, Issue 1, 2003, Pages 66-86

  Barrett, B ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Common cold; Coneflower; Echinacea; Immunomodulation, immunity; Immunostimulation; Upper respiratory infection

Indexed keywords

ECHINACEA PLUS; ECHINACEA PURPUREA EXTRACT; ECHINACIN; ECHINAFORCE; ECHINAGAARD; ECHINAGARD; ESBERITOX; VIRACEA;

ABDOMINAL PAIN; B LYMPHOCYTE; BURNING SENSATION; CLINICAL TRIAL; DIARRHEA; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DYSPHAGIA; ECHINACEA; ERYTHEMA NODOSUM; FEMALE; HERBAL MEDICINE; HUMAN; IMMUNOMODULATION; IMMUNOSTIMULATION; INFECTION RESISTANCE; INFLAMMATION; LEUKOCYTE ACTIVATION; MACROPHAGE ACTIVATION; MALE; MOUSE; NATURAL KILLER CELL; NAUSEA; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; REPRODUCTIVE TOXICITY; REVIEW; SIDE EFFECT; SKIN ALLERGY; SORE THROAT; T LYMPHOCYTE; TASTE DISORDER; UPPER RESPIRATORY TRACT INFECTION; URTICARIA; VOMITING;

ECHINACEA PURPUREA;

EID: 0037287797     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1078/094471103321648692     Document Type: Review

References (174)

1. Anonymous (2001) Monograph: Echinacea. Alternative Medicine Review 6: 411-414
2. Abbas AK, Lichtman AH, Pober JS (2000) 'Cellular and molecular immunology.' (W.B. Saunders: Philadelphia)
3. Abdullah T (2000) A strategic call to utilize Echinacea-garlic in flu-cold season. Journal of the National Medical Association 92: 48-51
4. American Academy of Allergy, Asthma and Immunology (2000) 'Echinacea can cause allergic reactions.' Press Release, March 2000. www.aaaai.org/media/pressreleases/2000/03/000307.html
5. Astin JA (1998) Why patients use alternative medicine: Results of a national study. JAMA 279: 1548-1553
6. Baetgen D (1984) Erfolge in der Keuchhusten-Behandlung mit Echinacin® [Successful treatment of whooping cough with Echinacea. Translator unknown.]. Therapiewoche 34: 5115-5119
7. Baetgen D (1988) Behandlung der akuten Bronchitis im Kindesalter. Praxisstudie mit einem Immunstimulans aus Echinacea purpurea [Treatment of acute bronchitis in children. A study of an immunostimulatory agent from Echinacea purpurea in a primary care setting. Translator unknown.]. Therapiewoche Pädiatrie 1: 65-70
8. Baraniuk JN (1992) Sensory, parasympathetic, and sympathetic neural influences in the nasal mucosa. J Allergy Clin Immunol 90: 1045-1050
9. Barrett B (2000) Echinacea for upper respiratory infection: An assessment of randomized trials. Health Notes: Review of Complementary and Integrative Medicine 7: 211-218
10. Barrett B, Kiefer D, Rabago D (1999a) Assessing the risks and benefits of herbal medicine: An overview of scientific evidence. Alternative Therapies in Health and Medicine 5:40-50
11. Barrett B, Vohmann M, Calabrese C (1999b) Echinacea for upper respiratory infection: Evidence-based clinical review. Journal of Family Practice 48: 628-635
12. Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, Servi D, Laffel G, Sweitz BJ (1995) Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA 274: 29-34
13. Bauer R (1996) Echinacea-Drogen: Wirkungen und Wirksubstanzen [Echinacea-containing drugs: Effects and active constituents. Translated by Beate V. Foit, Santa Cruz, CA.]. Zeitschrift fur Arztliche Fortbildung 90: 111-115
14. Bauer R (1998) Echinacea: Biological effects and active principles. In 'Phytomedicines of Europe: Chemistry and Biological Activity'. (Eds Lawson LD, Bauer R) pp 140-157 (American Chemical Society: Washington D.C.)
15. Bauer R (1999a) Chemistry, analysis and immunological investigations of Echinacea phytopharmaceuticals. In 'Immunomodulatory Agents from Plants'. (Ed Wagner H) pp 41-88 (Birkhauser Verlag: Basel, Boston, Berlin)
16. Bauer R (1999b) Standardization of Echinacea purpurea expressed juice with reference to cichoric acid and alkamides. Journal of Herbs, Spices & Medical Plants 6: 51-62
17. Bauer R (2000) In-vitro dissolution and bioavailability testing of Echinacea preparations - Feasible and reasonable? [Abstract - Third International Conference on Phytomedicine, Munich, Germany, October 11-13]. Phytomedicine Supplement II: 28
18. Bauer R, Foster S (1989) HPLC analysis of Echinacea simulata and E. paradoxa roots. Planta Medica 55: 637
19. Bauer R, Hoheisel O, Stuhlfauth I, Wolf H (1999) Preßsaft aus dem Kraut von Echinacea purpurea: Ein allopathisches Phytoimmununstimulans [Pressed juice from the herb of Echinacea purpurea. Translation by Beate V. Foit, Santa Cruz, CA.]. Wiener Medizinische Wochenschrift 149:185-189
20. Bauer R, Jurcic K, Puhlmann J, Wagner H (1988) Immunologische in-vivo-und in-vitro-Untersuchungen mit Echinacea-Extrakten [Immunological studies in vivo and in vitro of Echinacea extracts. Translated by Beate V. Foit, Santa Cruz, CA]. Arzneim-Forsch/Drug Res 38: 276-281
21. Bauer R, Remiger P, Jurcic K, Wagner H (1989) Beeinflussung der Phagozytose-Aktivität durch Echinacea-Extrakte [Influence of Echinacea extract on phagocytotic activity. Reviewed in translation, translator unknown]. Zeitschrift fur Phytotherapie 10: 43-48
22. Bauer R, Wagner H (1991) Echinacea species as potential immunostimulatory drugs. In 'Economic and Medicinal Plant Research'. (Eds Wagner H, Farnsworth NR) pp 253-318 (Academic Press Limited: New York)
23. Becker H (1982) Gegen Schlangenbiss und Grippe [Against snakebites and influenza: Utilization and chemical substances from Echinacea angustifolia and Echinacea purpurea. Translated by Beate V. Foit. Santa Cruz, CA]. Dtsch Apoth Ztg 122: 2320-2323
24. Becker L, Glazier R, McIsaac WJ, Smucny J (1999) 'Antibiotics for acute bronchitis.' (Cochrane Collaboration; Update Software, Oxford)
25. Becker SR (1996) Immunostimulation - Activation of physiological defence mechanisms. Schweiz Zschr GanzheitsMedizin: 1-3
26. Bent S, Saint S, Vittinghoff E, Grady D (2000) Antibiotics in acute bronchitis: A meta-analysis. The Americal Journal of Medicine 107: 62-67
27. Berg A, Northoff H, König D, Weinstock C, Grathwohl D, Parnham MJ, Stuhlfauth I, Keul J (1998) Influence of Echinacin (EC31) treatment on the exercise-induced immune response in athletes. Journal of Clinical Research 1: 367-380
28. Bergmann KC (1995) Assessment of the clinical value of using an immunomodulator in recurrent respiratory infections. Advances in Experimental Medicine & Biology 371B: 797
29. Beringer GM (1911) Fluid extract of Echinacea. American Journal of Pharmacy July 11, 324-325
30. Berman S, Justis JC, Tilles JG, Ma CB (1998) Dramatic increase in immune mediated HIV killing activity induced by Echinacea angustifolia. Int Conf AIDS 12, 582. Ref Type: Abstract
31. Binns SE, Inparajah I, Baum BR, Arnason JT (2001) Methyl jasmonate increases reported alkamides and ketoalkene/ynes in Echinacea pallida (Asteraceae). Phytochemistry 57: 417-420
32. Binns SE, Purgina B, Bergeron C, Smith ML, Ball L, Baum BR, Arnason JT (2000) Light-mediated antifungal activity of Echinacea extract. Planta Medica 66: 241-244
33. Blumenthal M, Goldberg A, Brinckmann J (2000) 'Herbal Medicine: Expanded Commission E Monographs.' (American Botanical Council: Austin, TX)
34. Blumenthal M, Goldberg A, Gruenwald J, Hall T, Riggins CW, Ristser RS, Kle S (1998) German Commission E Monographs: Therapeutic Monographs on Medicinal Plants for Human Use. American Botanical Council, Austin, Texas
35. Bodinet C, Beuscher N (1991) Antiviral and immunological activity of glycoproteins from Echinacea purpurea Radix. Planta Medica 57: 33
36. Bodinet C, Freudenstein J (1999) Effects of an orally applied aqueous-ethanolic extract of a mixture of Thujae occidentalis Herba, Baptisiae tinctoriae Radix, Echinaceae purpureae Radix and Echinaceae pallidae Radix on antibody response against sheep red blood cells in mice. Planta Medica 65: 695-699
37. Bodinet C, Willigmann I, Beuscher N (1993) Host resistance increasing activity of root extracts from Echinacea species. Planta Medica 59: 672-673
38. Bone K (1997a) Echinacea: What makes it work? Alternative Medicine Review 2: 87-89
39. Bone K (1997b) Echinacea: When should it be used? Alternative Medicine Review 2: 009-016
40. Bräunig B, Dorn M, Limburg E, Knick E, Bausendorf (1992) Echinaceae purpureae radix: Zur Stärkung der körpereigenen Abwehr bei grippalen Infekten [Strengthening of the endogenous resistence to influenzal infections. Translation by Ralph McElroy Co., Austin TX]. Zeitschrift fur Phytotherapie 13: 7-13
41. Brevoort P (1998) The Booming U.S. Botanical Market: A New Overview. HerbalGram 44: 33-46
42. Brewer T, Colditz GA (1999) Postmarking surveillance and adverse drug reactions. JAMA 281: 824-829
43. Brinkeborn RM, Shah DV, Degenring FH (1999) Echinaforce® and other Echinacea fresh plant preparations in the treatment of the common cold. Phytomedicine 6: 1-6
44. Bukovsky M, Vaverkova S, Kostalova D (1995) Immunomodulating activity of Echinacea gloriosa L., Echinacea angustifolia DC., and Rudbeckia speciosa Wenderoth ethanol-water extracts. Pol J Pharmacol 47: 175-177
45. Burger RA, Torres AR, Warren RP, Caldwell VD, Hughes BG (1997) Echinacea-induced cytokine production by human macrophages. International Journal of Immunopharmacology 19: 371-379
46. Carr RI, Laforce WM, Fry J, Kenney L, Lee TDG (1998) Echinacea: Stimulation of mouse spleen cells by commercial products. FASE Reports 12: A1082
47. Cetaruk EW, Aaron CK (1994) Hazards of nonprescription medications. Emergency Medicine Clinics of North America 12: 483-510
48. Coeugniet E, Kuhnast R (1986) Adjuvante Immuntherapie mit verschiedenen Echinacin®-Darreichungsformen [Recurrent candidiasis: Adjuvant immunotherapy with different formulations of Echinacin®. Translated by D. Wirth]. Therapiewoche 36: 1-19
49. Collet JP (1992) Immunomodulators and primary prevention of respiratory infections: Methodological considerations. Develop biol Standard 77: 159-165
50. Couch J, Giltner T (1921) An experimental study of Echinacea therapy. American Journal of Pharmacy March, 227-232
51. Cupp MJ (1999) Herbal remedies: Adverse effects and drug interactions. American Family Physician 59: 1239-1244
52. De Smet PAGM, Keller K, Hansel R, Chandler RF (1997) 'Adverse Effects of Herbal Drugs, Volume 3.' (Springer-Verlag: Berlin, Heidelberg & New York)
53. Dennehy C (2001) Need for additional, specific information in studies with Echinacea. Antimicrob Agents Chemother 45:369-370
54. Donohue M (2000) Several reports of allergic reactions attributed to Echinacea. Family Practice 29
55. Egert D, Beuscher N (1992) Studies on antigen specifity of immunoreactive arabinogalactan proteins extracted from Baptisia tinctoria and Echinacea purpurea. Planta Medica 58: 163-165
56. Eichler F, Krüger GRF (1994) Effects of non-specific immunostimulants (Echinacin, isoprinosine, and thymus factors) on the infection and antigen expression in herpesvirus-6 exposed human lymphoid cells. In Vivo 8: 565-576
57. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, Kessler RC (1998) Trends in alternative medicine use in the United States, 1990-1997. JAMA 280: 1569-1575
58. Elsasser-Beile U, Willenbacher W, Bartsch HH, Gallati H, Schulte Monting J (1996) Cytokine production in leukocyte cultures during therapy with Echinacea extract. Journal of Clinical Laboratory Analysis 10: 441-445
59. Emmendörffer AC, Wagner H, Lohmann-Matthes M-L (1999) Immunologically active polysaccharides from Echinacea purpurea plant and cell cultures. In 'Immunomodulatory Agents from Plants'. (Ed Wagner H) pp 89-104 (Birkhauser Verlag: Basel, Boston, Berlin)
60. Ernst E (1998) Harmless herbs? A review of the recent literature. American Journal of Medicine 104: 170-178
61. Evans AS, Kaslow RA (1997) 'Viral Infections of Humans.' (Plenum: New York)
62. Farr BM, Gwaltney JM, Hendley JO, Hayden FG, Naclerio RM, McBride T, Doyle WJ, Sorrentino JV, Riker DK, Proud D (1990) A randomized controlled trial of glucocorticoid prophylaxis against experimental rhinovirus infection. The Journal of Infectious Diseases 162: 1173-1177
63. Flannery MA (1999) From Rudbeckia to Echinacea: The emergence of the purple cone flower in modern therapeutics. Pharmacy in History 41: 52-59
64. Foster S (1991) 'Echinacea: Nature's Immune Enhancer.' (Healing Arts Press: Rochester, Vermont)
65. Foster S (1996) 'Echinacea: The Purple Coneflowers.' (American Botanical Council: Austin, TX)
66. Fugh-Berman A (2000) Herb-drug interactions. The Lancet 355: 134-138
67. Gallo M, Koren G (2001) Can herbal products be used safely during pregnancy? Focus on Echinacea. Canadian Family Physician 47: 1727-1728
68. Gallo M, Sarkar M, Au W, Pietrzak K, Comas B, Smith M, Jaeger TV, Einarson A, Koren G (2000) Pregnancy outcome following gestational exposure to Echinacea. Arch Intern Med 160: 3141-3143
69. Ganzera M, Pujol P, Walker L, Khan IA (2001) An improved method for the determination of betaine in Echinacea products. Pharmazie 56: 552-553
70. Garofalo R, Patel JA, Sim C, Schmalstieg FC, Goldman AS (1993) Production of cytokines by virus-infected human respiratory epithelial cells. J Allergy Clin Immunol 91: 177
71. Giles JT, Palat CT, Chien SH, Chang ZG, Kennedy DT (2000) Evaluation of Echinacea for treatment of the common cold. Pharmacotherapy 20: 690-697
72. Glasziou PP, Hayem M, Del Mar CB (1999) 'Antibiotics for acute otitis media in children.' (Cochrane Collaboration; Update Software, Oxford)
73. Grimm W, Muller HH (1999) A randomized controlled trial of the effect of fluid extract of Echinacea purpurea on incidence and severity of colds and respiratory infections. American Journal of Medicine 106: 138-144
74. Gunning K (1999) Echinacea in the treatment and prevention of upper respiratory tract infections. WJM 171: 198-200
75. Gustafson LM, Proud D, Hendley JO, Hayden FG, Gwaltney JM (1996) Oral prednisone therapy in experimental rhinovirus infections. J Allergy Clin Immunol 97: 1009-1014
76. Gwaltney JM (1985) Virology and immunology of the common cold. Rhinology 23: 265-271
77. Henneicke-von Zepelin HH, Hentschel C, Schnitker J, Kohnen R, Köhler G, Wüstenberg P (1999) Efficacy and safety of a fixed combination phytomedicine in the treatment of the comon cold (Acute viral respiratory tract infection): Results of a randomized, double blind, placebo controlled, multicentre study. Current Medical Research and Opinion 15: 214-227
78. Hobbs C (1995) 'Echinacea: The Immune Herb!' (Botanica Press, Santa Cruz, CA)
79. Hoheisel O, Sandberg M, Bertram S, Bulitta M, Schäfer M (1997) Echinagard treatment shortens the course of the common cold: A double-blind, placebo-controlled clinical trial. European Journal of Clinical Research 9: 261-268
80. Hu C, Kitts DD (2000) Studies on the antioxidant activity of Echinacea root extract. J Agric Food Chem 48: 1472
81. Hurlbert D (1999) Endangered Echinacea: What threat, which species, and where? UpS Newsletter 4-6
82. Igarashi Y, Skoner DP, Doyle WJ, White MV, Fireman P, Kaliner MA (1993) Analysis of nasal secretions during experimental rhinovirus upper respiratory infections. J Allergy Clin Immunol 92: 722-731
83. Jackson GG, Dowling HF, Anderson TO, Riff L, Saporta J, Turck M (1960) Susceptibility and immunity to common upper respiratory viral infections-the common cold. Annals of Internal Medicine 55: 719-738
84. Jackson GG, Dowling HF, Muldoon RL (1962) Present concepts of the common cold. Am J Public Health 52: 940-945
85. Jackson GG, Dowling HF, Spiesman IG, Boand AV (1958) Transmission of the common cold to volunteers under controlled conditions. Arch Intern Med 101: 267-278
86. Janeway CA, Travers P, Walport M, Capra JD (1999) 'Immunobiology: The immune system in health and disease.' (Current Biology Publications: London & New York)
87. Jurcic K, Melchart D, Holzmann M, Martin P, Bauer R, Doenecke A, Wagner H (1989) Zwei Probandenstudien zur Stimulierung der Granulozyten-Phagozytose durch Echinacea-extrakt-haltige Präparate [Two volunteer studies on the stimulation of granulocyte phagocytosis by preparations containing Echinacea extract. Translator unknown.]. Zeitschrift fur Phytotherapie 10: 67-70
88. Kaliner MA (1992) The physiology and pathophysiology of the parasympathetic nervous system in nasal disease: An overview. J Allergy Clin Immunol 90: 1044-1045
89. Korppi M, Kröger L (1992) C-reactive protein in viral and bacterial respiratory infection in children. Scand J Infec Dis 25: 207-213
90. Landmark Healthcare (1998) The Landmark report on public perceptions of alternative care. 1998 nationwide study of alternative care. Sacramento CA, Landmark Healthcare, Inc. Random telephone survey of 1500 households. Ref Type: Generic
91. Lenk W (1989) Akute toxizitat von verschiedenen polysacchariden Echinacea purpurea an der maus. [Acute toxicity of various polysaccharides from Echinacea purpurea in the mouse. Translated by, Beate V. Foit. Santa Cruz, CA]. Zeitschrift fur Phytotherapie 10: 49-51
92. Lersch C, Zeuner M, Bauer A, Siebenrock K, Hart R, Fink U, Dancygier H, Class M (1990) Stimulation of the immune response in outpatients with hepatocellular carcinomas by low doses of cyclophosphamide (LDCY), Echinacea purpurea extracts (Echinacin) and thymostimulin. Arch Geschwulstforsch 60: 379-383
93. Lersch C, Zeuner M, Bauer A, Siemens M, Hart R, Drescher M, Fink U, Dan H (1992) Nonspecific immunomodulation with low doses of cyclophosphamide (LDCY), thymostimulin, and Echinacea purpurea extracts (Echinacin) in patients with far advanced colorectal cancers. Cancer Investigation 10: 343-348
94. Li T (1998) 'Growing Echinacea.' (American Botanical Council, Austin, TX)
95. Lindenmuth GF, Lindenmuth EB (2000) The efficacy of Echinacea compound herbal tea preparation on the severity and duration of upper respiratory and flu symptoms: A randomized, double-blind placebo-controlled study. The Journal of Alternative and Complementary Medicine 6: 327-334
96. Livesey J, Awang DVC, Arnason JT, Letchamo W, Barrett M, Pennyroyal G (1999) Effect of temperature on stability of marker constituents in Echinacea purpurea root formulations. Phytomedicine 6: 347-349
97. Lohmann-Matthes M-L, Wagner H (1989) Aktivierung von Makrophagen durch Polysaccharide aus Gewebekulturen von Ecinacea purpurea [Activation of macrophages by polysaccharides from tissue cultures of Echinacea purpurea. Translation be Beate Foit, Santa Cruz, CA]. Zeitschrift fur Phytotherapie 10: 52-59
98. Lorenz E, MeBner H, Mutz I (1972) Leucocytokinetic studies during viral hepatitis. Zeitschrift fur Kinderheilkunde 113: 171-174
99. Luettig B, Steinmuller C, Gifford GE, Wagner H, Lohmann-Matthes &M-L (1989) Macrophage activation by the polysaccahride arabinogalactan isolated from plant cell cultures of Echinacea purpurea. Journal of the National Cancer Institute 81: 669-675
100. Mark JD, Grant KL, Barton LL (2001) The use of dietary supplements in pediatrics: A study of Echinacea. Clinical Pediatrics 40: 263-269
101. Mazza G, Cottrell T (1999) Volatile components of roots, stems, leaves, and flowers of Echinacea species. J Agric Food Chem 47: 3081-3085
102. McGregor RL (1968) The taxonomy of the genus Echinacea (Compositae). University of Kansas Science Bulletin 48: 113-142
103. Melchart D, Linde K (1999) Clinical investigations of Echinacea phytopharmaceuticals. In 'Immunomodulatory Agents from Plants'. (Ed Wagner H) pp 105-118 (Birkhauser Verlag: Basel, Boston, Berlin)
104. Melchart D, Linde K, Fischer P, Kaesmayr J (2000) 'Echinacea for preventing and treating the common cold.' (Cochrane Collaboration; Update Software; Oxford)
105. Melchart D, Linde K, Worku F, Bauer R, Wagner H (1994) Immunomodulation with Echinacea - a systematic review of controlled trials. Phytomedicine 1: 245-254
106. Melchart D, Linde K, Worku F, Sarkady L, Holzmann M, Jurcic K, Wagner H (1995) Results of five randomized studies on the immunomodulatory activity of preparations of Echinacea. Journal of Alternative and Complementary Medicine 1: 145-160
107. Melchart D, Walther E, Linde K, Brandmaier R, Lersch C (1998) Echinacea root extracts for the prevention of upper respiratory tract infections: A double-blind, placebo-controlled randomized trial. Archives of Family Medicine 7: 541-545
108. Mengs U, Clare CB, Poiley JA (1991) Toxicity of Echinacea purpurea. Arzneim-Forsch/Drug Res 41: 1076-1081
109. Mengs U, Leuschner J, Marshall RR (2000) Toxicity studies with Echinacin [Abstract - Third International Conference on Phytomedicine, Munich, Germany, October 11-13]. Phytomedicine Supplement II, 32
110. Messerschmidt K (2001) Natural alternatives for the common cold: hype or hope? S D J Med 54: 93-94
111. Mills S, Bone K (2000) 'Principles and practice of phytotherapy.' (Churchill Livingstone: Edinburgh, London, New York)
112. Monto AS (1995) Viral respiratory infections in the community: Epidemiology, agents, and interventions. American Journal of Medicine 99: 24S-27S
113. Möse JR (1983) [The effect of Echinacin® on phagocytic activity and natural killer cells. Translator unknown. Original German article not available]. Med Welt 34: 1463-1467
114. Müller-Jakic B, Breu W, Probstle A, Redl K, Greger H, Bauer R (1994) In vitro inhibition of cyclooxygenase and 5- lipooxygenase by alkamides from Echinacea and Achillea species. Planta Medica 60: 37-40
115. Mullins RJ (1998) Echinacea-associated anaphylaxis. Medical Journal of Australia 168: 170-171
116. Mullins RJ, Heddle R (2002) Adverse reactions associated with Echinacea: The Australian experience. Annals of Allergy, Asthma & Immunology 88: 42-51
117. Naclerio R, Proud D, Lichtenstein LM, Kagey-Sobotka A, Hendley JO, Sorrentino J, Gwaltney JM (1988) Kinins are generated during experimental rhinovirus colds. Journal of Infectious Disease 157: 133-142
118. Noah TL, Henderson FW, Wortman IA, Devlin RB, Handy J, Koren HS, Becker S (1995) Nasal cytokine production in viral acute upper respiratory infection of childhood. Journal of Infectious Disease 171: 584-592
119. Oeffinger KC, Snell LM, Foster BM, Panico KG, Archer RK (1997) Diagnosis of acute bronchitis in adults: A national survey of family physicians. Journal of Family Practice 45: 402
120. Panossian A, Wikman G, Wagner H (1999) Plant adaptogens III. Earlier and more recent aspects and concepts on their mode of action. Phytomedicine 6: 287-300
121. Parnham MJ (1996a) Benefit-risk assessment of the squeezed sap of the purple coneflower (Echinacea purpurea) for long-term oral immunostimulation. Phytomedicine 3: 95-102
122. Parnham MJ (1996b) Sonnenhut: Was ist dran an der Wirkung? [Echinacea purpurea: Is it really effective? Translation by Beate V. Foit, Santa Cruz, CA.]. Pharmazeutische Zeitung 141: 58-62
123. Parnham MJ (1999) Benefit and risks of the squeezed sap of the purple coneflower (Echinacea purpurea) for long-term oral immunostimulant therapy. In 'Immunomodulatory Agents from Plants'. (Ed Wagner H) pp 119-136 (Birkhauser Verlag: Basel, Boston, Berlin)
124. Percival SS (2000) Use of Echinacea in medicine. Biochemical Pharmacology 60: 153-158
125. Perry NB, Burgess EJ, Glennie VI (2001) Echinacea standardization: Analytical methods for phenolic compounds and typical levels in medicinal species. J Agric Food Chem 2001: 1702-1706
126. Perry NB, van Klink JW, Burgess EJ, Parmenter GA (1997) Alkamide levels in Echinacea purpurea: A rapid analytical methods revealing differences among roots, rhizomes, stems, leaves and flowers. Planta Medica 63: 58-62
127. Puckner WA (1909) Echinacea considered valueless: Report of the council on pharmacy and chemistry. Journal of the American Medical Association 1836
128. Reitz HD (1990) Immunmodulatoren mit pflanzlichen Wirkstoffen: eine wissenschaftliche Studie am Beispiel Esberitox N. Notabene medici 20: 362-366
129. Riedl-Seifert RJ, van Aubel A, Kammereit A, Elsasser U. (1995) Reduction of the number and severity of respiratory tract infections in children by oral immunostimulation. Advances in Experimental Medicine & Biology 371B: 799-802
130. Rininger JA, Kickner S, Chigurupati P, McLean A, Franck Z (2000) Immunopharmacological activity of Echinacea preparations following simulated digestion on murine macrophages and human peripheral blood mononuclear cells. Journal of Leukocyte Biology 68: 503-510
131. Röseler S, Holtappels G, Wagenmann M, Bachert C (1995) Elevated levels of interleukins IL-1 beta, IL-6 and IL-8 in naturally acquired viral rhinitis. European Archives of Oto-Rhino-Laryngology. Supplement 1: S61-S63
132. Rotblatt MD (1999) Herbal medicine: A practical guide to safety and quality assurance. Western Journal of Medicine 171: 172-175
133. Scaglione F, Lund B (1995) Efficacy in the treatment of the common cold of a preparation containing an Echinacea extract. Int J Immunopharmaocology 11 (4): 163-166
134. Scaglione F, Weiser K, Alessandria M (2001) Effects of the standardised ginseng extract G115® in patients with chronic bronchitis. Clin Drug Invest 21: 41-45
135. Schellenberg R (2001) Treatment for the premenstrual syndrome with agnus castus fruit extract: Prospective, randomised, placebo controlled study. BMJ 322: 134-137
136. Schimmer O, Erlangen, Abel G, Nurnberg, Behninger C (1989) Investigation of the genotoxic potency of a neutral polysaccharide from Echinacea tissue cultures in human lymphocyte cultures. Zeitschrift fur Phytotherapie 10: 39-42
137. Schöllhorn C, Schecklies E, Wagner H (1993) Immunochemical investigations of polysaccharides from Echinacea purpurea cell suspension cultures. Planta Medica 59: 662-663
138. Schöneberger D (1992) Einfluß der immunstimulierenden Wirkung von Preßsaft aus Echinacea purpurea auf Verlauf und Schweregrad von Erkältungskrankheiten [The influence of the immunostimulating effects of pressed juice from Echinacea purpurea on the course and severity of cold infections. Translations by Beate V. Foit, Santa Cruz CA and Sigrid M. Klien, January 20, 1993]. Forum Immunologie 8: 18-22
139. Schug BS, Blume HH (2000) Characterisation of the biopharmaceutic properties of Echinacea formulations in vivo: Are biomarkers a solution? [Abstract - Third International Conference on Phytomedicine, Munich, Germany, October 11-13]. Phytomedicine Supplement II: 28
140. Schulten B, Bulitta M, Ballering-Brühl B, Köster U, Schäfer M (2001) Efficacy of Echinacea purpurea in patients with a common cold: A placebo-controlled, randomised, double-blind clinical trial. Arzneim-Forsch/Drug Res 51: 563-568
141. See DM, Broumand N, Sahl L, Tilles JG (1997) In vitro effects of Echinacea and ginseng on natural killer and antibody-dependent cell cytotoxicity in healthy subjects and chronic fatigue syndrome or AIDS patients. Immunopharmacology 35: 229-235
142. Shalaby AS, El-Gengaihi SE, Agina EA, El-Khayat AS, Hendawy SF (1998) 'Horticultural Aspects of Growing Echinacea.' (American Botanical Council, Austin, TX)
143. Skwarek T, Tynecka Z, Glowniak K, Lutostanska E (1996) Echinacea L. - Inducer of interferons. Herba Polonica 42: 110-117
144. Sloley BD, Urichuk LJ, Tywin C, Coutts RT, Pang PKT, Shan JJ (2001) Comparison of chemical components and antioxidant capacity of difference Echinacea species. Journal of Pharmacy and Pharmacology 53: 849-857
145. Soon SL, Crawford RI (2001) Recurrent erythema nodosum associated with Echinacea herbal therapy. J Am Acad Dermatol 44: 298-299
146. Sperber SJ, Hendley JO, Hayden FG, Riker DK, Sorrentino JV, Gwaltney JM (1992) Effects of Naproxen on experimental rhinovirus colds. Annals of Internal Medicine 117: 37-41
147. Sperber SJ, Sorrentino JV, Riker DK, Hayden FG (2000) Evaluation of an alpha agonist alone and in combination with a nonsteroidal antiinflammatory agent in the treatment of experimental rhinovirus colds. Bulletin of N.Y.Academic Med 65:145-159
148. Steinmüller C, Roesler J, Grottrup E, Franke G, Wagner H, Lohmann-Matthes &M-L (1993) Polysaccharides isolated from plant cell cultures of Echinacea purpurea enhance the resistance of immunosuppressed mice against systemic infections with Candida albicans and Listeria. Int J Immunopharmacology 15: 605-614
149. Stimpel M (1984) Macrophage activation and induction of macrophage cytotoxicity by purified polysaccharide fractions from the plant Echinacea purpurea. Infection and Immunology 46: 845-849
150. Stotzem CD, Hungerland U, Mengs U (1992) Influence of Echinacea purpurea on the phagocytosis of human granolocytes. Medical Science Reseach 20: 719-720
151. Sun LZ-Y, Currier NL, Miller SC (2001) The American coneflower: A prophylactic role involving nonspecific immunity. The Journal of Alternative and Complementary Medicine 5: 427-446
152. Temte JL (2000) Treatment of influenza, The Journal of Family Practice 49: 81-82
153. Thompson KD (1998) Antiviral activity of Viracea® against acyclovir susceptible and acyclovir resistant strains of herpes simplex virus. Antiviral Research 39: 55-61
154. Tragni E, Galli CL, Tubaro A, del Negro P, Della Loggia R (1988) Anti-inflammatory activity of Echinacea angustifolia fractions separated on the basis of molecular weight. Pharmaceutical Research Communications 20 [Suppl V], 87-91. Ref Type: Abstract
155. Tragni E, Tubaro A, Melis S, Galli CL (1985) Evidence from two classic irritation tests for an anti-inflammatory action of a natural extract, Echinacina B. Food and Chemical Toxicology 23: 317-319
156. Tubaro A, Tragni E, del Negro P, Galli CL, Della Loggia R (1987) Anti-inflammatory activity of a polysaccharide fraction of Echinacea angustifolia. J Pharm Pharmacol 39: 567-569
157. Tunnerhoff FK, Schwabe HK (2001) Untersuchungen am Menschen und am Tier uber den Einfluss von Echinaceakonzentraten auf die kunstliche Bindegewebsbildung nach Fibrin-Implantationen. Heft 6: 330-334
158. Turner RB, Riker DK, Gangemi JD (2000) Ineffectiveness of Echinacea for prevention of experimental rhinovirus colds. Antimicrobial agents and chemotherapy 44: 1708-1709
159. Valleron AJ, Grimfeld A (1992) Evaluation of clinical trials of immunomodulators for prevention of recurrent respiratory infections in children. Develop biol Standard 77: 149-158
160. van Buchem FL, Knottnerus JA, Schrijnemaekers VJJ, Peeters MF (1997) Primary-care based randomised place-bo-controlled trial of antibiotic treatment in acute maxillary sinustis. Lancet 349: 683-687
161. Voaden D, Jacobson M (1972) Tumor Inhibitors. 3. Identification and Synthesis of an Oncolytic Hydrocarbon from American Coneflower Roots. Journal of Medicinal Chemistry 15: 619-623
162. Voitenko GM, Varchenko VG, Lipkan GM, Olinichenko PI, Myasoyedov DV, Mhitarian LS, Kutniak VP, Obedkova NM, Kukhar IV, Yakovleva NY, Naumova MI (1996) Influence of preparations from the roots and flowers of Echinacea purpurea on the course of the inflammatory reaction under experimental conditions. (Ukrainian). Farm Zh 2: 115-121
163. von Unruh V (1913) Achinacea angustifolia and Innla helenium in the treatment of tuberculosis. N.E.M.A. 63-75
164. Vorberg G, Schneider B (1984) Bei Erkältung unspezifische Immunabwehr stimulieren: Doppelblindstudie zeigt: Das bewährte Phytotherapeutikum Esberitox verkürzt die Symptomatik. Ärztliche Praxis 36: 97-98
165. Wagner H (1989) Search for new plant constituents with potential antiphlogistic and antiallergic activity. Planta Medica 55:235-241
166. Wagner H (1995) Immunostimulants and adaptogens from plants. In 'Phytochemistry of Medical Plants'. (Eds Amason JT, Mata R, Romeo JT) pp 1-18 (Plenum Press: New York)
167. Wagner H (1999) 'Immunomodulatory agents from plants.' (Birkhäuser Verlag: Basel, Boston, Berlin)
168. Wagner H, Kraus S, Jurcic K (1999) Search for potent immunostimulating agents from plants and other natural sources. In 'Immunomodulatory Agents from Plants'. (Ed Wagner H) pp 1-40 (Birkhauser Verlag: Basel, Boston, Berlin)
169. Wagner H, Proksch A, Riess-Maurer I, Vollmar A, Odenthal S, Stuppner H, Jurcic K, Le Turdu M, Heur Y (1984) Immunostimulant polysaccharides (heteroglycans) from higher plants. Arzneim-Forsch/Drug Res 34: 22-26.
170. Wagner H, Stuppner H, Schafer W, Zenk M (1988) Immunologically active polysaccharides of Echinacea purpurea cell cultures. Phytochemistry 27: 119-126
171. Wildfeuer A, Mayerhofer D (1994) Untersuchung des Einflusses von Phytopräparaten auf zelluläre Funktionen der körpereigenen Abwehr [The effects of plant preparations on cellular functions in body defense]. Arzneim-Forsch/Drug Res 44: 361-366
172. Willigmann I, Egert D, Bodinet C, Beuscher N (1993) Chemical and immunological properties of the immunomodulatory active compounds from the roots of different Echinacea species. Planta Medica 59: 671-673
173. Wolf H, Schwarz T, Odenthal KP (1998) Phagocytosis-promoting activities of Echinacin® the stabilized pressed juice of Echinacea purpurea. Scientia Pharmaceutica 66: S 127
174. Zoutewelle G (1990) Effects of Echinacea purpurea extracts on fibroblast populated collagen ladder contraction. Phytotherapy Research 4: 77-84